D. E. Shaw & Co., Inc. Johnson & Johnson Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $4.82 Million - $5.54 Million	-33,100 Reduced 20.2%	130,800 $21.2 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $17.5 Million - $19.1 Million	-121,300 Reduced 42.53%	163,900 $24 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $9.5 Million - $9.96 Million	-61,200 Reduced 17.67%	285,200 $45.1 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $2.56 Million - $2.8 Million	17,600 Added 5.35%	346,400 $54.3 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $13.7 Million - $15.4 Million	88,000 Added 36.54%	328,800 $51.2 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $21.9 Million - $23.6 Million	142,200 Added 144.22%	240,800 $39.9 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $16.8 Million - $20.1 Million	-111,400 Reduced 53.05%	98,600 $15.3 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $4.69 Million - $5.27 Million	-29,300 Reduced 12.24%	210,000 $37.1 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $6.21 Million - $6.91 Million	-38,500 Reduced 13.86%	239,300 $39.1 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $6.69 Million - $7.4 Million	39,800 Added 16.72%	277,800 $49.3 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $16.6 Million - $18.9 Million	-105,100 Reduced 30.63%	238,000 $42.2 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $10.7 Million - $11.9 Million	68,900 Added 25.13%	343,100 $58.7 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $11.6 Million - $12.9 Million	-71,600 Reduced 20.71%	274,200 $44.3 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $27.9 Million - $29.9 Million	174,700 Added 102.1%	345,800 $57 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $7.18 Million - $8 Million	46,900 Added 37.76%	171,100 $28.1 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $2.87 Million - $3.29 Million	-20,900 Reduced 14.4%	124,200 $19.5 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $21.8 Million - $23.9 Million	-155,300 Reduced 51.7%	145,100 $21.6 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $12.9 Million - $15.6 Million	100,400 Added 50.2%	300,400 $42.2 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $20.6 Million - $28.5 Million	185,000 Added 1233.33%	200,000 $26.2 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $2.55 Million - $2.93 Million	-20,000 Reduced 57.14%	15,000 $2.19 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $7.49 Million - $8.39 Million	-59,000 Reduced 62.77%	35,000 $4.53 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $19.7 Million - $23.7 Million	-160,300 Reduced 63.04%	94,000 $12.1 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $5.67 Million - $6.66 Million	46,600 Added 22.44%	254,300 $35.1 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $31.3 Million - $34.6 Million	-262,300 Reduced 55.81%	207,700 $25.2 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $12.3 Million - $14.6 Million	-98,300 Reduced 17.3%	470,000 $60.2 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $9.25 Million - $10.1 Million	-70,500 Reduced 11.04%	568,300 $79.4 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $82.7 Million - $86.5 Million	638,800	638,800 $83.1 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account